Podcast

Understanding longevity - Weighing up the impact of obesity drugs

calendar icon 13 March 2025

Key topics discussed

  • What weight loss drugs are available and how they work
  • The risks associated with the drugs
  • The potential impact of weight loss drugs on mortality from an insurer’s perspective

Overview

In this episode of Hymans Robertson On... Understanding Longevity, our hosts, Nicola Green and Kara Scott, are joined by Daniel Ryan, Director of Demographic Risk & Data Science at Just Group, to discuss weight loss drugs.

During this episode, our experts explore:

  • What weight loss drugs are available and how they work.
  • The risks associated with the drugs.
  • The potential impact of weight loss drugs on mortality from an insurer’s perspective.

If you have any questions about the topics discussed in this podcast, please get in touch.

Hymans Robertson disclaimer

This podcast has been prepared by Hymans Robertson LLP, and is based upon our understanding of events as at release date. It is designed to be a general summary of topical investment matters and is not specific to the circumstances of any particular employer or pension scheme. The information contained in this podcast should not be construed as advice and not be considered as a substitute for specific advice as the information is generic in nature. Where a podcast refers to legal matters please note that Hymans Robertson is not qualified to provide legal opinion and therefore you may wish to obtain independent legal advice to consider any relevant law and/or regulation. Hymans Robertson LLP accepts no liability for errors or omissions. Your Hymans Robertson LLP consultant will be pleased to discuss matters raised in this podcast in greater detail. Guests views are separate to that of Hymans Robertson.

The information provided in this broadcast is not financial advice. Past performance is not a guide to the future. Please note the value of investments, and income from them, may fall as well as rise. This includes but is not limited to equities, government or corporate bonds, derivatives and property, whether held directly or in a pooled or collective investment vehicle. Further, investments in developing or emerging markets may be more volatile and less marketable than in mature markets. Exchange rates may also affect the value of investments. As a result, an investor may not get back the full amount of the original investment. Past performance is not necessarily a guide to future performance. 

Hymans Robertson LLP is authorised and regulated by the Financial Conduct Authority and Licensed by the Institute and Faculty of Actuaries for a range of investment business activities.

Speakers

Nicola Torley
Opens in new window

Nicola Green

Consultant

Kara Scott
Opens in new window

Kara Scott

Consultant

Sign up for our newsletter

We pride ourselves on being thought leaders and are constantly discussing the many issues facing and shaping our industry. Sign up to find our current thinking on topical issues.

Opens in new window Subscribe
  • Latest industry news

  • First access to upcoming events

  • Content tailored to your interests

  • Access to exclusive content

Opens in new window Subscribe